Skip to content

Assessment of the effect of precision-optimized Pay-it-forward Intervention strategy on improving HPV vaccination rates among females aged 15-18: A three-arm clustered randomized controlled trial

Assessment of the effect of precision-optimized Pay-it-forward Intervention strategy on improving HPV vaccination rates among females aged 15-18: A three-arm clustered randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079291
Enrollment
Unknown
Registered
2023-12-29
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

"Pay-it-forward":1.Prevention of HPV and cervical cancer, the importance, effectiveness, and safety of HPV vaccines (Scan the QR code to watch the video). 2.Receive a heartfelt postcard and social car
Postcard Group:1.Prevention of HPV and cervical cancer, the importance, effectiveness, and safety of HPV vaccines (Scan the QR code to watch the video). 2.Receive a compassionate postcard and social c
Subsidy Group:1.Receive 330 RMB in specialized health promotion funds supported by charitable contributions from others. 2.Have the opportunity to donate and inspire others to get vaccinated, spreadin

Sponsors

West China School of Public Health, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are females: 1) aged 15–18years; 2) with no HPV vaccination history, 3) with no prior allergies to vaccines; and 4) have a legal guardian who consents to participate the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria are females: 1) aged below 15 or above 18years;2) received HPV vaccine(s); 3) ineligible to receive a vaccine based on clinical evaluation from a physician; or 4) a legal guardian refuses to consent to participate.

Design outcomes

Primary

MeasureTime frame
First-dose HPV vaccine uptake;

Secondary

MeasureTime frame
Vaccine delay;Vaccine confidence;Economic evaluation;Donation Rate/Amount in the 'Pay-It-Forward' Group and Subsidy Group.;community engagement;

Countries

China

Contacts

Public ContactLi Jing

West China School of Public Health, Sichuan University

lijingwcph@scu.edu.cn+86 132 4022 5540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026